CA153 / CA153-M

Test Code CA153 / CA153-M 
Test CANCER ANTIGEN 15-3 (CA 15-3), SERUM 
Methodology Enzyme-Labeled Sandwich Immunoassay 
Description Useful for predicting early recurrence in women treated for carcinoma of the breast, and for serial testing in women with prior stage II or III breast cancer who are clinically free of disease

NOTE: This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policy "Tumor Antigen by Immunoassay CA 15-3/CA 27.29". Please verify that the diagnosis code (ICD-9) you have chosen demonstrates medical necessity for the test as documented in the physician's patient record. The CMS web site or the NorDx Limited Coverage Documentation Guide are available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD-9 code chosen. 

Specimen Draw blood in either a plain, red-top tube(s) or a serum gel tube(s). Spin down and send 1.0 mL (minimum 0.3 mL) of serum refrigerated in a screw-capped, plastic vial. 
Reference Values Males: < 30 U/mL (use not defined)
Females: < 30 U/mL 
Analytic Time 1 Day 
Day(s) Test Set Up Monday through Friday, Saturday 
CPT Code(s) 86300